Corcept Therapeutics, Inc. (CORT)
73.34
+0.72
(+0.99%)
USD |
NASDAQ |
Jun 08, 16:00
73.34
0.00 (0.00%)
After-Hours: 17:33
Corcept Therapeutics Total Assets (Quarterly) : 814.88M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Abeona Therapeutics, Inc. | 198.49M |
| Merck & Co., Inc. | 128.68B |
| Liquidia Corp. | 401.53M |
| Indivior Pharmaceuticals, Inc. | 1.197B |
| ANI Pharmaceuticals, Inc. | 1.422B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 176.89M |
| Shareholders Equity (Quarterly) | 637.99M |
| Debt to Equity Ratio | 0.0151 |
| Current Ratio | 2.826 |
| Net Debt Paydown Yield | -0.01% |